Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Ardigen is a Krakow company founded in 2014 as a spin-off of the drug discovery group Selvita. It combines bioinformatics, artificial intelligence and software engineering for precision medicine, immunotherapy and microbiome research. The company works with pharmaceutical companies in Europe and the United States.
News
Phenotypic Profiling & Screening, Ardigen phenAID
Accelerate phenotypic drug discovery with Ardigen phenAID. Our AI-driven platform uses morphological profiling & cell image analysis to find better drug candidates.
Read more
Report
Target Identification and Validation Services
Target identification and validation using multimodal data, evidence weighting, druggability assessment and traceable prioritization.
Read more
Report
AI Biologics Development Services
AI biologics development services powered by AI for antibody and protein discovery, engineering, developability assessment and lead optimization
Read more
Report
AI for Small Molecule Drug Discovery
Small molecule discovery services using AI for cheminformatics, virtual screening, property prediction, generative design and lead optimization.
Read more
Report
AI for Clinical Trials and Clinical Drug Development
We Streamline clinical research, optimize trial design, and enhance patient outcomes through AI-driven solutions for clinical trial efficiency.
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.